Polynucleotides (PDRN) from HTL Biotechnology

HTL Biotechnology is a French biotech and a pionner and world leader in the development and sustainable bioproduction of pharmaceutical-grade biopolymers (Hyaluronic acid, Polynucleotides), used to develop life-changing treatments for millions of patients worldwide. Our premium quality biopolymers are used by healthcare companies for the development of treatments in various cutting-edge therapeutic areas such as ophthalmology, dermatology, medical aesthetics and rheumatology.

For over 30 years, our teams have been developing and perfecting an innovative pharmaceutical-grade biopolymer platform that provides customized solutions to pharmaceutical laboratories and medical device manufacturers worldwide. HTL Biotechnology recently reinforced its position as a world leader in the development of pharmaceutical-grade biopolymers by...

Read full company description
Address: 7 Rue Alfred Kastler, 35133, Javené
France
France Local time:

30+ years of expertise

Made in France

Tailor-made products : wide range of Intrinsic Viscosity

Our clients:

Aesthetics, Dermatology, Ophthalmology, Rheumatology leaders

Our services:

R&D support
Regulatory support
Quality support
Flexible supply

Response time:

Produced in:

France

MOQ: -

  • CoA

  • GMP

  • FDA

  • MSDS

  • USDMF

  • KDMF

Contact supplier

Replies quickly

HTL Biotechnology Polynucleotides (PDRN) API Producer - 100403-24-5

Description:
HTL Biotechnology offers high-quality Polynucleotides (PDRN) API, certified for compliance with international standards. Manufactured in France from 1992. 30+ years of expertise. Made in France. Tailor-made products : wide range of Intrinsic Viscosity.

Product Details

Certifications
CoA, GMP, FDA, MSDS, USDMF, KDMF compliant
Minimum Order Quantity
Produced in
France (Europe)
CAS Number
100403-24-5
Raw Material Category
Dermatics

Ordering Process

1. Inquiry Submission: Click "Send Inquiry" to connect directly with producer.

2. Requirement Specification: Outline your needs for tailored offers.

3. Quotation: Receive the best quote and terms exclusively through Pharmaoffer.

Quality Assurance

HTL Biotechnology has successfully passed audits conducted by Eurofins, with reports available that underscore the company's commitment to quality and transparency.

Additional Products

We offer 3 other Active Pharmaceutical Ingredients and excipients, showcasing our production and distribution capabilities.

Contact Us

Are you looking for Polynucleotides (PDRN) API? Contact HTL Biotechnology by using the send inquiry button. We will respond quickly with pricing and terms exclusively through Pharmaoffer.

Please, provide enough information regarding your inquiry. Let us know whether you require Ph.Eur (EP), USP, BP, JP grade, whether you are looking for hydrochloride (HCl), base, or other specific product specifications. Additionally, please inform us if the API is intended for your own production, resale, or research purposes. Contact us to receive a quote, download certificates, and purchase the Polynucleotides (PDRN) API

HTL Biotechnology


HTL Biotechnology is a French biotech and a pionner and world leader in the development and sustainable bioproduction of pharmaceutical-grade biopolymers (Hyaluronic acid, Polynucleotides), used to develop life-changing treatments for millions of patients worldwide. Our premium quality biopolymers are used by healthcare companies for the development of treatments in various cutting-edge therapeutic areas such as ophthalmology, dermatology, medical aesthetics and rheumatology.

For over 30 years, our teams have been developing and perfecting an innovative pharmaceutical-grade biopolymer platform that provides customized solutions to pharmaceutical laboratories and medical device manufacturers worldwide. HTL Biotechnology recently reinforced its position as a world leader in the development of pharmaceutical-grade biopolymers by acquiring, through its subsidiary HTL Biotechnology Innovation Inc (HTL BII – New Jersey), a recombinant protein platform whose most advanced product is recombinant human collagen type III (rhCOL3) within a world-class scientific research center.

Today, HTL Biotechnology continues to play a driving role in innovation in the sector, collaborating with research entities and biotechnology companies to meet unmet medical needs (regenerative medicine, drug delivery, etc.).